English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background:  Forkhead box “O” one which is member of Forkhead box family of transcription factors is known to play key role in different physiological processes including cell cycle arrest, autophagy, and apoptosis.  FOXO1  is defined to play tumor suppressive role in various malignancies including breast cancer and its Dysregulation is frequently reported. However, the evaluation of  FOXO1  promoter methylation and its expression at mRNA and protein level in different stages of breast cancer and its association with different clinical parameters is still not studied. Therefore, for better understanding the role of  FOXO1  in breast cancer, in our study we examined the  FOXO1  mRNA and protein expression in Breast cancer samples of Indian breast cancer patients.   Results:  Total 127 breast cancer samples along with adjacent normal tissue ( n = 127 ) were analyzed through methylation specific PCR (MS-PCR), mRNA expression (Real-time PCR) and Immunohistochemistry (IHC). We detected 69.29% cases to be downregulated at the mRNA level, and 77.95% of cases exhibited no or low protein expression. In our data we report a significant association ( p = 0.0001 ) between the downregulated protein expression and promoter hypermethylation of  FOXO1  gene. We also found a significant correlation of  FOXO1  mRNA level with Age ( p = 0.008 ), age at first live birth ( p = 0,003 ), tumor size ( p = 0.05 ) and lymph node status ( p = 0.01 ).   Conclusion:  we in our study report the tumor suppressive role of  FOXO1  in case of Indian breast cancer patients and our data suggest it to exhibit prognostic importance. However, further research is needed to evaluate  FOXO1  significance in diagnostic and therapeutic targeting in breast cancer cases.

FOXO1 Gene Downregulation and Promoter Methylation Exhibits Significant Correlation With Clinical Parameters in Indian Breast Cancer Patients